Biomea also drilled down into subgroups of patients with mild age-related diabetes and severe insulin-deficient diabetes, ...

Currently indicated to improve glycemic control in adults with diabetes, the company announced 6-month results from its Phase ...

Technological advances have profoundly affected people living with type 1 diabetes, their families or carers, and health-care ...

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

HPH-15, a compound developed by Kumamoto University, reduces blood glucose and fat accumulation more effectively than ...

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders. This often ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the ...

In her award-winning essay, young British science writer Jasmin Notarangelo carried out a very personal investigation into a pressing global health issue that affects her family directly.

Dec. 12, 2024 — Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular ...

In use for some 60 years, scientists really didn't know exactly how metformin worked to lower blood sugar levels — until now.

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...